Shi Jingwei, Zheng Jingtong, Huang Honglan, Hu Yu, Bian Jiang, Xu Deqi, Li Fan
Department of Pathogenobiology, Norman Bethune Medical College of Jilin University, Changchun, Jilin Province, China.
Virus Genes. 2011 Dec;43(3):319-26. doi: 10.1007/s11262-011-0638-0. Epub 2011 Jun 24.
The incidence of measles in China has increased over the last decade. To evaluate the genetic variation of measles strains, 16 measles wild-type virus strains were isolated from 14 vaccinated cases and 2 nonvaccinated cases in Jilin Province during 2005-2006, and their nucleoprotein (N) and hemagglutinin (H) genes were amplified by RT-PCR. The amplified products were sequenced and compared with the Edmonston virus and the existing vaccine strains (Changchun-47 and Shanghai-191). The results showed that the variation rate between the vaccine and wild-type strains was 9.8-12.0% in the N gene and 5.9-6.9% in the H gene, respectively. In addition, cross-neutralization assays revealed that although sera obtained from infants following primary vaccination effectively neutralized vaccine strains, the capacity in neutralizing H1 wild-type measles virus isolates was decreased fourfold. Antigenic ratios testing revealed that the antigenic relatedness between wild-type measles viruses and existing vaccine strains was notably low. These data suggest that the increased incidence of measles in Jilin Province may be attributed to the antigenic drift between wild-type and vaccine strains. Our findings strengthen the recommendation of supplemental immunization with existing vaccines and also strongly suggest a need for developing new vaccines to better control measles virus outbreaks.
在过去十年间,中国麻疹的发病率有所上升。为评估麻疹病毒株的基因变异情况,于2005 - 2006年从吉林省的14例接种疫苗病例和2例未接种疫苗病例中分离出16株麻疹野毒株,采用逆转录聚合酶链反应(RT-PCR)扩增其核蛋白(N)基因和血凝素(H)基因。对扩增产物进行测序,并与埃德蒙斯顿病毒以及现有的疫苗株(长春-47和上海-191)进行比较。结果显示,疫苗株与野毒株在N基因上的变异率分别为9.8 - 12.0%,在H基因上的变异率分别为5.9 - 6.9%。此外,交叉中和试验表明,尽管初次接种疫苗的婴儿血清能有效中和疫苗株,但中和H1麻疹野毒株的能力降低了四倍。抗原比率检测显示,麻疹野毒株与现有疫苗株之间的抗原相关性显著较低。这些数据表明,吉林省麻疹发病率的上升可能归因于野毒株与疫苗株之间的抗原漂移。我们的研究结果强化了使用现有疫苗进行补充免疫的建议,也强烈表明需要研发新疫苗以更好地控制麻疹病毒的爆发。